Smite the Monstrous is a 2011 white instant from the Innistrad expansion in Magic: The Gathering, numbered 33 in the set.
Smite the Monstrous
2011 • Magic: The Gathering • Innistrad
No Listings Available
No listings available right now.
Price History
Description
Smite the Monstrous is a white instant card from the 2011 Innistrad expansion of Magic: The Gathering, designated as card number 33. Created by artist Jason Felix, this common rarity card costs {3}{W} to cast and targets creatures with a power of 4 or greater, effectively removing larger threats from the battlefield. The flavor text reflects the Gothic horror themes of the Innistrad block, referencing the failing wards and enduring faith in Avacyn that defines the setting. For collectors of Magic: The Gathering, this card represents a specific moment in the game's history, capturing the aesthetic and mechanical identity of the Innistrad era. Collectors often seek out individual cards to complete set collections or to explore the unique design language of this release. Whether you are building a library or simply appreciating the art and mechanics of the time, this card offers a tangible connection to the 2011 release.
Have one of these to sell?
We'll pre-fill the product details from this catalog entry, so your listing lands on this exact page. Just add photos of your copy, pick its condition, and set your price.
Card Details
The catalog profile below summarizes the card identity, featured subject, and notable collectible traits.
Catalog Profile
The core identity of the card within the set.
Featured Subject
The subject, team, league, and sport context tied to this card.
Featured
Smite the Monstrous
Game
Magic: The Gathering
TCG Attributes
Rarity, print treatment, and game-specific stats for this card.
Common
Jason Felix
Card Stock
English
{3}{W}
Instant
W
Card Text
Abilities, attacks, oracle text, and flavor text printed on the card.
Destroy target creature with power 4 or greater.
Though the old holy wards and roadside shrines have begun to fail, faith in Avacyn still holds true power.
